op 10 report is based on a combination of primary and secondary information sources, including Venture Planning Group's proprietary database, developed during the firm's continuous monitoring of the industry, as well as over 100 syndicated multiclient studies and numerous proprietary single-client assignments. This database contains information on major life science intermediates companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the Top 10 companies' product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Contains 600 pages and 84 tables
SECTION I. EXECUTIVE SUMMARY
- A 3-5 page synopsis of main sections.
SECTION II. BUSINESS ORGANIZATION
- History of the life science intermediates business
evolution, important to the understanding of the
corporate culture, management mentality and strategies.
- Recent acquisitions, divestitures and significant
- Current organizational structure.
SECTION III. SENIOR MANAGEMENT
- Background of key executives.
SECTION IV. FACILITIES AND EMPLOYEES
- Major administrative, manufacturing
and R&D facilities in the U.S. and abroad.
- New plants under construction.
- U.S. and international work force size and distribution.
SECTION V.TECHNOLOGICAL KNOW-HOW
- Internally developed and acquired technologies, and
- Proprietary technologies and patent litigations.
SECTION VI. PRODUCT PORTFOLIO
- Extensive review of major product lines.
- New product introductions and line extensions.
SECTION VII. MARKETING TACTICS
- Major promotional strategies.
- Distribution approaches.
- Product service and support.
SECTION VIII. FINANCIAL ANALYSIS
- Sales and operating profit by division, prodPage: 1 2 3 4 5 6 Related medicine technology :1
. Reportlinker Adds US Disposable Medical Supplies Market Report2
. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile3
. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech4
. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery5
. Reportlinker Adds Reinventing Pharmaceutical Sales Forces6
. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 20147
. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery8
. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 20159
. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities10
. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis11
. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)